Lupin receives Form 483 with 2 observations after US FDA inspection at Ankleshwar facility

https://misryoum.com/us/markets/lupin-receives-form-483-with-2-observations-after/

Drug firm Lupin Ltd on Saturday (March 7) said the US Food and Drug Administration (US FDA) has concluded an inspection of its manufacturing facility in Ankleshwar, India, issuing a Form 483 with two observations.The inspection was conducted between March...

#Lupin #receives #Form #483 #with #observations #after #FDA #inspection #Ankleshwar #facility #US_News_Hub #misryoum_com